Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults "OPTIMYST"


Phase 3 Results N/A

Summary of Purpose

Multicenter, open-label, outpatient study of the safety and effectiveness of repeated doses of MYOBLOC over a 1-year duration in adult subjects with troublesome sialorrhea.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 24 October 2017.

1 Oct 2015 2 Nov 2015 1 Jun 2017 1 Jun 2017 1 Oct 2017 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics




Trial Design

  • Masking: Open Label
  • Purpose: Treatment
  • Endpoint: Safety/Efficacy Study
  • Intervention: Single Group Assignment